Intra-Cellular Therapies Inc (ITCI)
86.17
-0.37
(-0.43%)
USD |
NASDAQ |
Nov 04, 16:00
86.16
-0.01
(-0.01%)
After-Hours: 20:00
Intra-Cellular Therapies Market Cap: 9.135B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 9.135B |
| November 01, 2024 | 9.175B |
| October 31, 2024 | 8.985B |
| October 30, 2024 | 9.061B |
| October 29, 2024 | 8.137B |
| October 28, 2024 | 8.144B |
| October 25, 2024 | 8.036B |
| October 24, 2024 | 8.018B |
| October 23, 2024 | 7.952B |
| October 22, 2024 | 8.171B |
| October 21, 2024 | 8.152B |
| October 18, 2024 | 8.304B |
| October 17, 2024 | 8.340B |
| October 16, 2024 | 8.065B |
| October 15, 2024 | 7.919B |
| October 14, 2024 | 7.827B |
| October 11, 2024 | 8.030B |
| October 10, 2024 | 7.803B |
| October 09, 2024 | 7.763B |
| October 08, 2024 | 7.673B |
| October 07, 2024 | 7.546B |
| October 04, 2024 | 7.726B |
| October 03, 2024 | 7.658B |
| October 02, 2024 | 7.698B |
| October 01, 2024 | 7.701B |
| Date | Value |
|---|---|
| September 30, 2024 | 7.756B |
| September 27, 2024 | 7.745B |
| September 26, 2024 | 7.736B |
| September 25, 2024 | 7.858B |
| September 24, 2024 | 7.980B |
| September 23, 2024 | 8.011B |
| September 20, 2024 | 8.201B |
| September 19, 2024 | 8.133B |
| September 18, 2024 | 7.893B |
| September 17, 2024 | 7.937B |
| September 16, 2024 | 7.952B |
| September 13, 2024 | 7.965B |
| September 12, 2024 | 7.948B |
| September 11, 2024 | 7.895B |
| September 10, 2024 | 7.773B |
| September 09, 2024 | 7.863B |
| September 06, 2024 | 7.771B |
| September 05, 2024 | 7.652B |
| September 04, 2024 | 7.678B |
| September 03, 2024 | 7.714B |
| August 30, 2024 | 7.743B |
| August 29, 2024 | 7.635B |
| August 28, 2024 | 7.689B |
| August 27, 2024 | 7.807B |
| August 26, 2024 | 7.871B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
478.01M
Minimum
Nov 18 2019
9.175B
Maximum
Nov 01 2024
4.267B
Average
4.540B
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals Inc | 2.425B |
| Ionis Pharmaceuticals Inc | 6.059B |
| Madrigal Pharmaceuticals Inc | 7.226B |
| AbbVie Inc | 354.26B |
| Arcus Biosciences Inc | 1.423B |
Market Cap Related Metrics
| PS Ratio | 14.16 |
| Price to Book Value | 7.980 |
| Price | 86.17 |
| Earnings Yield | -1.01% |